Volume | 158,923 |
|
|||||
News | - | ||||||
Day High | 0.1732 | Low High |
|||||
Day Low | 0.1652 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ReShape Lifesciences Inc | RSLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.1685 | 0.1652 | 0.1732 | 0.1669 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
330 | 158,923 | $ 0.1701184 | $ 27,036 | - | 0.1414 - 2.798 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:13:04 | 2 | $ 0.1685 | USD |
ReShape Lifesciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.99M | 23.46M | - | 8.68M | -11.39M | -0.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ReShape Lifesciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSLS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.161 | 0.177 | 0.16 | 0.166869 | 204,978 | 0.0071 | 4.41% |
1 Month | 0.1825 | 0.209 | 0.158 | 0.1719941 | 342,965 | -0.0144 | -7.89% |
3 Months | 0.213 | 0.2245 | 0.1414 | 0.1727801 | 511,856 | -0.0449 | -21.08% |
6 Months | 0.201 | 0.59 | 0.1414 | 0.3119087 | 3,614,025 | -0.0329 | -16.37% |
1 Year | 2.75 | 2.798 | 0.1414 | 0.3473163 | 2,297,111 | -2.58 | -93.89% |
3 Years | 475.00 | 475.00 | 0.1414 | 76.04 | 1,514,733 | -474.83 | -99.96% |
5 Years | 475.00 | 475.00 | 0.1414 | 76.04 | 1,514,733 | -474.83 | -99.96% |
ReShape Lifesciences Description
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. |